Successful compounds that meet safety and efficacy criteria in clinical trials may obtain regulatory approval for use in the market as anti-inflammatory and analgesic agents.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
3-[2-(6-chloropyridazin-3-ylamino)phenylamino]-1H-pyrazol-5(4H)-one
1-cyclopropyl-3-(4-(5-(2,2-difluoropropyl)-6a-methyl-6-oxo-5,6,6a,7,9,10-hexahydro[1,4]oxazino[3,4-h]pteridin-2-yl)phenyl)urea
